Open Access

Shared decision-making for gene therapy in haemophilia care

Simon Fletcher

Simon Fletcher

Haemnet LtdLondon, UK
Orcid profile
Search for this author on
Sciendo|Google Scholar
Fletcher, Simon
, 
Kathryn Jenner

Kathryn Jenner

Haemnet LtdLondon, UK
Orcid profile
Search for this author on
Sciendo|Google Scholar
Jenner, Kathryn
 and 
Kate Khair

Kate Khair

Haemnet LtdLondon, UK
Orcid profile
Search for this author on
Sciendo|Google Scholar
Khair, Kate
  
Aug 09, 2023
Shared decision-making for gene therapy in haemophilia care's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Clinical Practice
Published Online: Aug 09, 2023
Page range: 62 - 67
DOI: https://doi.org/10.2478/jhp-2023-0009
Keywords
© 2023 Simon Fletcher et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option

Figure 1.

The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]
Language:
English
Publication timeframe:
1 times per year
Journal Subjects:
Medicine, Basic Medical Science, Basic Medical Science, other, Clinical Medicine, Clinical Medicine, other, Pharmacy, Pharmacology
Journal RSS Feed